WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2016> 32> 3

Volume: 32 Issue: 3

1. Metabolic syndrome and fatty liver Page:407—410
2. Nonalcoholic fatty liver disease and hepatocellular carcinoma Page:432—436
3. Nonalcoholic fatty liver disease and serum uric acid Page:437—441
4. Role of cell senescence in development and progression of nonalcoholic fatty liver disease Page:442—445
5. Research advances in susceptibility genes and their role in the pathogenesis of nonalcoholic fatty liver disease Page:446—452
6. Current status of nonalcoholic fatty liver disease and related risk factors: an analysis of an enterprise in Xi′an Page:463—466
7. Classification tree model analysis of influencing factors for hepatocyte steatosis in patients with chronic hepatitis B Page:476—479
8. Genotypes and resistance loci in patients with chronic hepatitis B achieving virologic breakthrough in treatment with lamivudine combined with adefovir after developing drug resistance in treatment with lamivudine alone Page:480—483
9. Effects of HBV X protein on expression and promoter methylation of p16 tumor suppressor gene Page:484—487
10. Clinical manifestations and pathological features of congenital hepatic fibrosis: an analysis of 13 patients Page:488—490
11. Clinical value of apparent diffusion coefficient in classification of liver fibrosis in chronic liver diseases Page:491—494
12. Correlation between serum levels of complement C5a and liver fibrosis markers in patients with obstructive jaundice Page:495—498
13. Relationship of hyponatremia with degree of liver injury and prognosis in patients with decompensated liver cirrhosis Page:499—502
14. Clinical effect of precise sequential interventional therapy in patients with unresectable hepatic metastasis after surgery for colorectal cancer Page:518—521
15. Effect of ursodeoxycholic acid on bile secretion after endoscopic nasobiliary drainage in patients with cholestatic liver disease of various causes Page:522—525
16. Effect of laparoscopic cholecystectomy on aminotransferase levels in patients with hyperlipidemia Page:526—529
17. Efficacy of incision and drainage versus percutaneous catheter drainage in treatment of severe acute pancreatitis complicated by pancreatic abscess Page:530—532
18. Therapeutic effect of gemcitabine hydrochloride combined with stereotactic radiotherapy for locally advanced pancreatic cancer Page:537—540
19. Current status of research on nonalcoholic fatty liver disease in China Page:552—556
20. Research advances in natural drugs for prevention and treatment of nonalcoholic fatty liver disease Page:557—560
21. Role of dietary intervention in nonalcoholic fatty liver disease Page:561—564
22. Association between nonalcoholic fatty liver disease and malignant transformation of hepatocytes Page:565—569
23. Role of liver immunological inflammation in development and progression of nonalcoholic fatty liver disease Page:570—573
24. Role of inflammatory factors in development and progression of alcoholic liver disease Page:574—578
25. Research advances in paternal-fetal vertical transmission during HBV infection Page:579—583
26. Research advances in association between Toll-like receptor 4 and hepatitis B Page:584—587
27. Application of magnetic resonance elastography as a non-invasive technique for diagnosis of liver fibrosis Page:588—592
28. Research advances in electroencephalographic monitoring of minimal hepatic encephalopathy Page:593—596
29. Research advances in mesenchymal stem cells from various sources in treatment of liver fibrosis Page:597—600
30. Research advances in application of molecular-targeted therapy for hepatocellular carcinoma Page:601—604
31. Research advances in renal replacement therapy for hepatorenal syndrome Page:605—608
32. Role of UGT1A1 gene polymorphism in the pathogenesis of Gilbert syndrome Page:609—612

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.